Presented by
Management Forum
Lunch & Learn
In this talk, explore how the Pharmaceutical Quality System (PQS) impacts the financials of an organisation and how it can enhance an organisation's financial strength.
Part of L&L: Making Financial Sense of GMP series:
Are you aware of how the GxP requirements impact the financials of an organisation? This exciting series provides a concise overview of some key elements of GxP such as Pharmaceutical Quality System, Validation Master Plan, Risk Management and Change Management. Participants will learn about how these elements impact the gross profit, operational costs and net profit.
What is Lunch & Learn? Turn your lunch hour into a valuable learning opportunity with our all-new Lunch & Learn category – an exciting twist on the traditional webinar, starting in 2025. These bite-sized, budget-friendly and diverse training sessions are designed to fit seamlessly into your working day, providing a flexible and impactful way to advance your skills without disrupting your busy schedule.
If you’re looking to boost your professional expertise, our Lunch & Learn courses combine the latest insights, expert-led instruction, and practical tools to keep you engaged and evolving — all in the time it takes to enjoy your lunch!
So, what are you waiting for? Learn something new, grow your career, and make every minute count.
From £99! Our Lunch & Learn short courses start from just £99 (early booking price) when you book 5 or more places - any combination of multiple courses for one attendee, or multiple attendees on the same course.
Pharmaceutical Quality System (PQS) is outlined in ICH Q10 guideline. The PQS is referred to as ICH Q10 Model and is based on International Standards Organisation (ISO) quality concepts, includes applicable Good Manufacturing Practice (GMP) regulations and complements ICH Q8 'Pharmaceutical Development' and ICH Q9 'Quality Risk Management'.
The implementation of ICH Q10 model aims to achieve three main objectives and complements or enhances regional GMP requirements:
There is intrinsic financial impact on each of these objectives and understanding it supports not only improving quality efforts, but aligns with financial and budgetary goals.
ICH Q10 is a model and regulatory expectation. What would happen if the regulatory expectation was removed?
This course is part of our GxP training (Good x Practice) course collection, which features a variety of topic areas to ensure you comply with the most recent quality guidelines. For more information on the latest EU GMP regulations, see our GMP training course covering the Annex 1.
Attending this session will help deepen your knowledge and support your understanding on how the objectives of ICH Q10 model benefits an organisation's financial performance.
The benefits of attending this session include:
This session is designed for senior life science professionals involved with Pharmaceutical Quality System (PQS) either directly or indirectly.
The stakeholders are typically from executive and management roles responsible for and involved in decision making and striving to balance financial goals with compliance and quality requirements.
Other interested stakeholders not directly involved with compliance or quality include:
Jitan Bhudia is a highly accomplished Pharmaceutical Consultant with extensive expertise in Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), and regulatory compliance within the pharmaceutical industry. With a career spanning over two decades, Jitan has a proven track record of leading business operations, ensuring regulatory compliance, and driving commercial success in pharmaceutical manufacturing and distribution.
As the co-founder of jarmatrixpharma.com, a site dedicated to help organisations “manage knowledge”, Jitan has provided specialized consulting and tailored training solutions for pharmaceutical manufacturing. He has designed and implemented Quality and Document Management Systems, supported regulatory audits, and worked closely with industry stakeholders to ensure compliance with stringent pharmaceutical regulations. His ability to develop cost-effective compliance solutions and deliver expert training on quality management strategies has positioned him as a trusted advisor in the field.
Previously, Jitan served as the Owner, Director, and Head of Production at Percuro Medica Limited, where he played a pivotal role in establishing and expanding the company. Under his leadership, the company gained essential licenses from the MHRA and the Home Office for the manufacture and distribution of controlled drugs. His expertise in facility design, validation, and risk management helped secure major contracts with pharmaceutical companies.
With his deep industry knowledge, regulatory expertise, and business acumen, Jitan continues to support pharmaceutical organizations in navigating complex compliance landscapes, optimizing quality systems, and achieving operational excellence.
13 June 2025
Lunch & Learn
Live online
12:00-13:30 UK (London) (UTC+01)
13:00-14:30 Paris (UTC+02)
07:00-08:30 New York (UTC-04)
Course code 15636
Until 06 Jun
Not ready to book yet?
for 7 days, no obligation
3 October 2025
Lunch & Learn
Live online
12:00-13:30 UK (London) (UTC+01)
13:00-14:30 Paris (UTC+02)
07:00-08:30 New York (UTC-04)
Course code 15637
Until 26 Sep
Not ready to book yet?
for 7 days, no obligation
13 February 2026
Lunch & Learn
Live online
12:00-13:30 UK (London) (UTC+00)
13:00-14:30 Paris (UTC+01)
07:00-08:30 New York (UTC-05)
Course code 15638
Until 06 Feb
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.
Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to: